IFN-alpha-2b vs Thymogen
Head-to-head comparison of IFN-alpha-2b (Recombinant human interferon alfa-2b) and Thymogen (L-Glutamyl-L-Tryptophan) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | IFN-alpha-2b | Thymogen |
|---|---|---|
| Category | Immune Support | Immune Support |
| Full Name | Recombinant human interferon alfa-2b | L-Glutamyl-L-Tryptophan |
| Molecular Weight | ~19,300 Da | 345.34 Da |
| Half-Life | 2-8 hours | 1-2 h |
| Amino Acids | 165 | 2 |
| Typical Dose | 3-10 million IU | 100-300 mcg |
| Route | Subcutaneous/Intramuscular | Intranasal |
| Purity | ≥98% | ≥98% |
| Studies Count | 2000 | 60 |
| Research Status | Clinical | Clinical |
IFN-alpha-2b Benefits
- ✓broad antiviral signaling
- ✓innate immune activation
- ✓reduced viral replication
- ✓clinical immunomodulation
Thymogen Benefits
- ✓cellular-immune-support
- ✓t-cell-signaling
- ✓recovery-adjunct
- ✓infection-resilience
IFN-alpha-2b Dosing
3-10 million IU per dose|Subcutaneous or intramuscular administration|Monitor CBC, liver enzymes, and mood
Thymogen Dosing
100-300 mcg/day|intranasal or IM|5-10 day cycles
IFN-alpha-2b Side Effects
- ⚠flu-like symptoms
- ⚠depression or mood changes
- ⚠cytopenias
Thymogen Side Effects
- ⚠nasal irritation
- ⚠headache
- ⚠hypersensitivity
Research Overview
IFN-alpha-2b
Extensively studied recombinant type I interferon with direct antiviral and immunoregulatory effects. Clinical literature spans hepatitis treatment, antiviral research, and immune-oncology contexts.
Thymogen
Thymogen has been studied as a short thymic peptide-like dipeptide with immunoregulatory activity. The literature focuses on lymphocyte function, cytokine modulation, and use in recurrent respiratory infections or immune suppression states.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.